Pesticides Reports, Notices and Documents

Pesticides Reports, Notices and Documents

Feb 28, 1994: Comments of DPR's RCD for Mevinphos
OEHHA has provided a number of comments on the risk characterization methodology and conclusions on the draft RCD for Mevinphos.
Nov 15, 1993: Comments of DPR's RCD for Hydrogen Cyanamide
OEHHA has provided a number of comments on the risk characterization methodology and conclusions on the draft RCD for Hydrogen Cyanamide.
Sep 17, 1993: Comments of DPR's RCD for Cycloate
OEHHA has provided a number of comments on the risk characterization methodology and conclusions on the draft RCD for Cycloate.
Jul 13, 1993: Comments of DPR's RCD for Paclobutrazol
OEHHA has provided a number of comments on the risk characterization methodology and conclusions on the draft RCD for Paclobutrazol.
Jul 12, 1993: Comments of DPR's RCD for Abamectin
OEHHA has provided a number of comments on the risk characterization methodology and conclusions on the draft RCD for Abamectin.
Jul 24, 1992: Comments of DPR's RCD for Abamectin
OEHHA has provided a number of comments on the risk characterization methodology and conclusions on the draft RCD for Abamectin.
Jun 11, 1992: Comments of DPR's RCD for Malathion, Chlorpyrifos, and Bensulfuron Methyl
OEHHA has provided a number of comments on the risk characterization methodology and conclusions on the draft RCD for Malathion, Chlorpyrifos, and Bensulfuron Methyl.
Dec 30, 1991: Comments of DPR's EAD for Abamectin
OEHHA has provided a number of comments on the exposure assessment methodology and conclusions on the draft EAD for Abamectin.
Dec 23, 1991: Comments of DPR's RCD for Permethrin
OEHHA has provided a number of comments on the risk characterization methodology and conclusions on the draft RCD for Permethrin.
Oct 7, 1991: Comments of DPR's RCD for Bifenthrin
OEHHA has provided a number of comments on the risk characterization methodology and conclusions on the draft RCD for Bifenthrin.
Sep 12, 1991: Comments of DPR's RCD and EAD for Bromoxynil Octanoate
OEHHA has provided a number of comments on the risk characterization methodology and conclusions on the draft RCD and EAD for Bromoxynil Octanoate.

Pages